Monopar Therapeutics (MNPR) SEC Filings — 2024
33 SEC filings for Monopar Therapeutics (MNPR) in 2024.
Filings
- Monopar Therapeutics Files 8-K: Material Agreement & Equity Sales — 8-K · Dec 23, 2024
- Tactic Pharma LLC Amends Monopar Therapeutics Stake — SC 13D/A · Dec 17, 2024
- Monopar Therapeutics Files 8-K — 8-K · Dec 6, 2024
- Monopar Therapeutics Files 8-K on Financials — 8-K · Nov 8, 2024
- Monopar Therapeutics SC 13G Filing — SC 13G · Nov 6, 2024
- Monopar Therapeutics SC 13G Filing — SC 13G · Oct 31, 2024
- Monopar Therapeutics Files 8-K: Material Agreement — 8-K · Oct 30, 2024
- Monopar Therapeutics SC 13G Filing — SC 13G · Oct 28, 2024
- Monopar Therapeutics SC 13G Filing — SC 13G · Oct 24, 2024
- Monopar Therapeutics Files 8-K: Acquisition, Debt, and Equity Sales — 8-K · Oct 24, 2024
- Monopar Therapeutics Files 8-K — 8-K · Oct 22, 2024
- Monopar Therapeutics Files 8-K — 8-K · Oct 15, 2024
- Monopar Therapeutics Files 8-K — 8-K · Oct 7, 2024
- Monopar Therapeutics Files 8-K — 8-K · Sep 12, 2024
- Monopar Therapeutics Files 8-K Report — 8-K · Aug 27, 2024
- Monopar Therapeutics Files 8-K — 8-K · Aug 21, 2024
- Monopar Therapeutics Files 8-K — 8-K · Aug 14, 2024
- Monopar Therapeutics Q2 2024 10-Q Filed — 10-Q · Aug 9, 2024
- Monopar Therapeutics Sets August 5th Annual Meeting — DEF 14A · Jul 22, 2024
- Monopar Therapeutics Files 8-K — 8-K · Jul 9, 2024
- Monopar Therapeutics Files 8-K — 8-K · Jun 11, 2024
- Monopar Therapeutics Files 8-K — 8-K · Jun 10, 2024
- Monopar Therapeutics Appoints New Chief Medical Officer — 8-K · May 24, 2024
- Monopar Therapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- Monopar Therapeutics Files 8-K Report — 8-K · Apr 16, 2024
- Monopar Therapeutics Files 8-K — 8-K · Apr 10, 2024
- Monopar Therapeutics Files 8-K — 8-K · Mar 28, 2024
- Monopar Therapeutics Files 8-K for Regulation FD Disclosure — 8-K · Mar 7, 2024
- Monopar Therapeutics Files 8-K: Financials & Exhibits — 8-K · Mar 5, 2024
- Monopar Therapeutics Faces Potential Delisting Notice — 8-K · Feb 28, 2024
- Monopar Therapeutics Files 8-K Current Report — 8-K · Feb 27, 2024
- Monopar Therapeutics Files 8-K for Regulation FD Disclosure — 8-K · Feb 22, 2024
- Monopar Therapeutics Files 8-K for Regulation FD Disclosure — 8-K · Feb 20, 2024